Get the Stockscreener App
163.32
0.65%
1.05
After Hours:
163.32
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $163.32, with a volume of 657.05K.
It is up +0.65% in the last 24 hours and up +5.34% over the past month.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$162.27
Open:
$162.05
24h Volume:
657.05K
Relative Volume:
0.86
Market Cap:
$18.22B
Revenue:
$9.54B
Net Income/Loss:
$841.00M
P/E Ratio:
24.52
EPS:
6.66
Net Cash Flow:
$1.02B
1W Performance:
+1.24%
1M Performance:
+5.34%
6M Performance:
+15.60%
1Y Performance:
+20.70%
1-Day Range:
$161.64
$163.88
1-Week Range:
$160.33
$165.32
52-Week Range:
$123.04
$165.32
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Compare DGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
163.32 | 18.22B | 9.54B | 841.00M | 1.02B | 6.66 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-28-24 | Resumed | Evercore ISI | In-line |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-29-23 | Initiated | Piper Sandler | Neutral |
| May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
| Jan-23-23 | Initiated | Evercore ISI | In-line |
| Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-22 | Downgrade | UBS | Buy → Neutral |
| Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| May-04-21 | Upgrade | UBS | Neutral → Buy |
| Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-21-20 | Upgrade | Argus | Hold → Buy |
| Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-19 | Resumed | Credit Suisse | Neutral |
| Jan-31-19 | Downgrade | Argus | Buy → Hold |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
Quest Diagnostics Incorporated (NYSE:DGX) Shares Purchased by BNP Paribas Financial Markets - MarketBeat
Swedbank AB Boosts Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Stock Holdings Boosted by Citigroup Inc. - MarketBeat
Thrivent Financial for Lutherans Buys 9,396 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
What Are Wall Street Analysts' Target Price for Quest Diagnostics Stock? - MSN
What Are Wall Street Analysts' Target Price For Quest Diagnostics Stock? - Barchart
Charles Schwab Investment Management Inc. Has $109.93 Million Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Eagle Asset Management Inc. Invests $2.29 Million in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics stock hits 52-week high at $165.11 By Investing.com - Investing.com Canada
B. Metzler seel. Sohn & Co. Holding AG Acquires New Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
Icon Wealth Advisors LLC Boosts Stock Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024 - GuruFocus.com
Landscape Capital Management L.L.C. Makes New Investment in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Intech Investment Management LLC Has $10.37 Million Stake in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Ontario Teachers Pension Plan Board - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics (STU:QDI) Change In Inventory : €0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Quest Diagnostics (STU:QDI) Total Assets : €14,502 Mil (As of Sep. 2024) - GuruFocus.com
Quest Diagnostics (DGX) Up 2.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Quest Diagnostics Incorporated (NYSE:DGX) Stock Holdings Lifted by Natixis Advisors LLC - MarketBeat
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Here's Why You Should Retain DGX Stock in Your Portfolio Now - MSN
Hilton Capital Management LLC Invests $8.84 Million in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Banque Cantonale Vaudoise Sells 8,627 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
LMR Partners LLP Makes New $1.02 Million Investment in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Partners LLC Has $1.33 Million Stock Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Empowered Funds LLC Raises Stake in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics (NYSE:DGX) Reaches New 1-Year HighHere's What Happened - MarketBeat
Quest Diagnostics stock hits 52-week high of $162.68 By Investing.com - Investing.com Canada
IVY Lane Capital Management LLC Purchases 10,000 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Vitamin D Testing Market Size to Reach USD 1774.70 Million by 2031 | SkyQuest Technology - Benzinga
Quest Diagnostics Incorporated (NYSE:DGX) Shares Acquired by Mizuho Securities USA LLC - MarketBeat
ING Groep NV Grows Stock Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management - BioSpace
Q3 EPS Estimates for Quest Diagnostics Cut by Zacks Research - MarketBeat
Quest Diagnostics Incorporated's (NYSE:DGX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? - Yahoo Finance
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch
January 2025 Options Now Available For Quest Diagnostics (DGX) - Nasdaq
All You Need to Know About Quest Diagnostics (DGX) Rating Upgrade to Buy - Yahoo Finance
Quest Diagnostics Incorporated (NYSE:DGX) Shares Purchased by Arjuna Capital - MarketBeat
Is Quest Diagnostics Stock a Smart Addition to Your Portfolio Now? - Yahoo Finance
Quest Diagnostics Incorporated (NYSE:DGX) Stock Position Lessened by Van ECK Associates Corp - MarketBeat
Quest Diagnostics Declares Quarterly Cash Dividend - PR Newswire
Victory Capital Management Inc. Sells 419,365 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Versor Investments LP Acquires 3,583 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Quest Diagnostics (NYSE:DGX) Hits New 12-Month HighStill a Buy? - MarketBeat
Quest Diagnostics stock hits 52-week high of $161.1 By Investing.com - Investing.com Canada
Kennebec Savings Bank Buys Shares of 3,823 Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):